Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
579
-
Total 13F shares, excl. options
-
202M
-
Shares change
-
+5.6M
-
Total reported value, excl. options
-
$10.6B
-
Value change
-
+$298M
-
Put/Call ratio
-
0.43
-
Number of buys
-
282
-
Number of sells
-
-196
-
Price
-
$52.66
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q2 2021
630 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q2 2021.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 579 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 202M shares
of 1.23B outstanding shares and own 16.49% of the company stock.
Largest 10 shareholders include Dodge & Cox (70.3M shares), Fisher Asset Management, LLC (17.9M shares), FMR LLC (16.5M shares), BlackRock Inc. (14.5M shares), BANK OF AMERICA CORP /DE/ (9.92M shares), Invesco Ltd. (5.43M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (5.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.38M shares), LAZARD ASSET MANAGEMENT LLC (3.26M shares), and Parametric Portfolio Associates LLC (3.01M shares).
This table shows the top 579 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.